Future Growth Opportunities in the Arteriovenous Malformation Market
The Arteriovenous Malformation Market offers significant growth opportunities, particularly in emerging regions where healthcare infrastructure is improving. Increased awareness of AVM diagnosis and minimally invasive treatment options is driving adoption.
R&D in novel embolic agents and combined therapy approaches is also creating new avenues for growth. Expansion of specialty clinics and advanced hospitals is expected to further increase patient access to AVM treatments worldwide.
Market Outlook: The global market, worth USD 1.1 billion in 2024, is forecast to reach USD 2.4 billion by 2034, registering a 7.0% CAGR.
1 View